13F filing recap · Q2 2023

What did Brave Warrior Advisors buy in Q2 2023?

Reported stock-position changes between this filing and the previous one.

Stock value

$3.78B

Positions

Estimated turnover

7.2%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

MPLXMplx LP$407.3Kreported value+12.0K shares CMAComerica Inc$317.7Kreported value+7.5K shares ICLRICON PLC$237.7Kreported value+950 shares WFCWells Fargo & Company/mn$224.1Kreported value+5.3K shares MARMarriott International Inc /md/$219.3Kreported value+1.2K shares

Increased positions

ELVElevance Health, Inc.$587.03Mreported value+236.5K shares+21.8%LADLithia Motors, Inc.$348.89Mreported value+77.4K shares+7.2%FNFFidelity National Financial, Inc.$327.17Mreported value+2.4K shares+0.0%OMFOnemain Holdings, Inc.$233.81Mreported value+58.0K shares

Reduced positions

APOApollo Global Management, Inc.$604.83Mreported value-35.8K shares-0.5%PRIPrimerica, Inc.$424.00Mreported value-7.1K shares-0.3%JPMJPMorgan Chase & Co$245.46Mreported value-10.0K shares-0.6%RJFRaymond James Financial Inc$224.59Mreported value-12.2K shares

Exited positions

SCHWSchwab Charles Corp$275.0Kprior reported value-5.3K shares-100.0%